Calculating pH-solubility profile and pHmax for monoprotic salts of poorly water-soluble weak bases

被引:0
作者
Meng, Fan [1 ]
Ibrahim, Fady [1 ]
机构
[1] Sanofi US, CMC Formulat, Synthet Platform, 350 Water St, Cambridge, MA 02141 USA
关键词
Pharmaceutical Salt; pH-solubility; pHmax; Salt disproportionation; Solubility prediction; PHARMACEUTICAL SALTS; DEPENDENT SOLUBILITY; CHEMICAL-STABILITY; DRUG; DISPROPORTIONATION; DISSOLUTION; SELECTION; FORMS; COUNTERION; ACIDS;
D O I
10.1016/j.ijpharm.2025.125338
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pharmaceutical salts are a commonly used strategy to improve the bioavailability of poorly water-soluble active pharmaceutical ingredients (APIs). The selected salt form is expected to have high solubility to obtain optimal supersaturation and sufficient physical stability for adequate shelf life. In this paper, we aim to develop equations to describe critical parameters of salts, including pH-solubility profile and pHmax. The equations serve as a valuable tool to aid in the calculation of salt solubility at pH below the pHmax in the presence of common counter ions. This provides the knowledge to assess the risks of pre-selection of the salt formers without the necessity of salt synthesis. The solubilities calculated by this model demonstrate good agreement with experimental solubility results reported in the literature. Compared to the conventional approaches for salt solubility and pHmax calculation, our model stands out, especially for poorly water-soluble bases with low pKa values, which benefit the most from salt formation. Moreover, the equations are used to support the concept that salt selection should focus on finding salt forms with sufficient solubility, rather than the most soluble salt, as excessively high solubility could be detrimental to physical stability.
引用
收藏
页数:12
相关论文
共 55 条
  • [1] Effect of Excipients on Salt Disproportionation during Dissolution: A Novel Application of In Situ Raman Imaging
    Abouselo, Amjad
    Rance, Graham A.
    Tres, Francesco
    Taylor, Lynne S.
    Kwokal, Ana
    Renou, Ludovic
    Scurr, David J.
    Burley, Jonathan C.
    Aylott, Jonathan W.
    [J]. MOLECULAR PHARMACEUTICS, 2021, 18 (09) : 3247 - 3259
  • [2] ENHANCEMENT OF SOLUBILITY OF DRUG SALTS BY HYDROPHILIC COUNTERIONS - PROPERTIES OF ORGANIC SALTS OF AN ANTIMALARIAL DRUG
    AGHARKAR, S
    LINDENBAUM, S
    HIGUCHI, T
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (05) : 747 - 749
  • [3] PREDICTIVE RELATIONSHIPS IN THE WATER SOLUBILITY OF SALTS OF A NONSTEROIDAL ANTI-INFLAMMATORY DRUG
    ANDERSON, BD
    CONRADI, RA
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (08) : 815 - 820
  • [4] Solubility of sparingly-soluble ionizable drugs
    Avdeef, Alex
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) : 568 - 590
  • [5] Salt Solubility and Disproportionation - Uses and Limitations of Equations for pHmax and the In-silico Prediction of pHmax
    Avdeef, Alex
    Sugano, Kiyohiko
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 111 (01) : 225 - 246
  • [6] Disproportionation of Pharmaceutical Salts: pHmax and Phase-Solubility/pH Variance
    Avdeef, Alex
    [J]. MOLECULAR PHARMACEUTICS, 2021, 18 (07) : 2724 - 2743
  • [7] Salt selection and optimisation procedures for pharmaceutical new chemical entities
    Bastin, RJ
    Bowker, MJ
    Slater, BJ
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2000, 4 (05) : 427 - 435
  • [8] Structure, solubility, screening, and synthesis of molecular salts
    Black, Simon N.
    Collier, Edwin A.
    Davey, Roger J.
    Roberts, Ron J.
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (05) : 1053 - 1068
  • [9] SOLUBILITY OF DOXYCYCLINE IN AQUEOUS-SOLUTION
    BOGARDUS, JB
    BLACKWOOD, RK
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (02) : 188 - 194
  • [10] Bowker MJ, 2008, PRACTICE OF MEDICINAL CHEMISTRY, 3RD EDITION, P749